Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
1076
DELISTED
Cadence Bank
CADE
| $7.94M | 0.01% |
404,323
+154,839
| +62% | +$3.05M |
|
1077
Healthcare Realty
HR
$6.84B
| $7.94M | 0.01% |
420,943
+99,593
| +31% | +$1.92M |
|
1078
CALL
S&P Global
SPGI
$120B
| $7.94M | 0.01% |
+19,800
| New | +$7.23M |
|
1079
New York Times
NYT
$10.2B
| $7.93M | 0.01% |
201,278
+100,704
| +100% | +$3.83M |
|
|
CEQP
1080
DELISTED
Crestwood Equity Partners LP
CEQP
| $7.91M | 0.01% |
298,716
-280,961
| -48% | -$7.13M |
|
1081
NetEase
NTES
$84.7B
| $7.91M | 0.01% |
81,759
-103,532
| -56% | -$9.35M |
|
1082
BioNTech
BNTX
$23.5B
| $7.9M | 0.01% |
73,227
-27,932
| -28% | -$3.14M |
|
1083
CALL
Magna International
MGA
$18.8B
| $7.9M | 0.01% |
140,000
| – | – |
|
|
NS
1084
DELISTED
NuStar Energy L.P.
NS
| $7.9M | 0.01% |
460,875
-206,924
| -31% | -$3.38M |
|
1085
Teva Pharmaceuticals
TEVA
$41.2B
| $7.9M | 0.01% |
1,048,700
-736,245
| -41% | -$5.97M |
|
|
AZPN
1086
DELISTED
Aspen Technology Inc
AZPN
| $7.89M | 0.01% |
47,075
+19,378
| +70% | +$3.6M |
|
1087
Option Care Health
OPCH
$3.56B
| $7.89M | 0.01% |
242,785
-26,458
| -10% | -$798K |
|
1088
Reinsurance Group of America
RGA
$16.1B
| $7.88M | 0.01% |
56,818
+24,936
| +78% | +$3.55M |
|
|
PACW
1089
DELISTED
PacWest Bancorp
PACW
| $7.85M | 0.01% |
963,315
+692,512
| +256% | +$5.58M |
|
1090
Encompass Health
EHC
$12.4B
| $7.83M | 0.01% |
115,640
+40,645
| +54% | +$2.55M |
|
|
TEF
1091
DELISTED
Telefonica
TEF
| $7.8M | ﹤0.01% |
1,934,542
+1,803,656
| +1,378% | +$7.65M |
|
1092
Agilon Health
AGL
$1.6B
| $7.78M | ﹤0.01% |
17,956
+17,427
| +3,294% | +$9.79M |
|
1093
Universal Display
OLED
$4.19B
| $7.74M | ﹤0.01% |
53,683
+19,532
| +57% | +$2.8M |
|
1094
PUT
PNC Financial Services
PNC
$101B
| $7.73M | ﹤0.01% |
+61,400
| New | +$7.5M |
|
1095
PUT
Becton Dickinson
BDX
$48.7B
| $7.71M | ﹤0.01% |
+29,200
| New | +$7.42M |
|
1096
iShares Russell 1000 Value ETF
IWD
$83.7B
| $7.7M | ﹤0.01% |
48,810
+798
| +2% | +$122K |
|
1097
Lazard
LAZ
$4.31B
| $7.7M | ﹤0.01% |
240,723
+18,766
| +8% | +$580K |
|
|
LTHM
1098
DELISTED
Livent Corporation
LTHM
| $7.7M | ﹤0.01% |
280,758
+13,049
| +5% | +$313K |
|
1099
Yeti Holdings
YETI
$3.95B
| $7.69M | ﹤0.01% |
198,109
+131,921
| +199% | +$5.11M |
|
1100
Timken Company
TKR
$9.03B
| $7.69M | ﹤0.01% |
84,048
+44,656
| +113% | +$3.52M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.